| 1 |
33318047 | RET inhibition in novel patient-derived models of RET-fusion positive lung adenocarcinoma reveals a role for MYC upregulation. | 2020 Dec 14 |
3 |
| 2 |
29908090 | Drug resistance profiles of mutations in the RET kinase domain. | 2018 Sep |
2 |
| 3 |
28751462 | Selective MET Kinase Inhibition in MET-Dependent Glioma Models Alters Gene Expression and Induces Tumor Plasticity. | 2017 Nov |
1 |
| 4 |
27496134 | Preclinical Modeling of KIF5B-RET Fusion Lung Adenocarcinoma. | 2016 Oct |
1 |
| 5 |
25351743 | Cabozantinib overcomes crizotinib resistance in ROS1 fusion-positive cancer. | 2015 Jan 1 |
1 |
| 6 |
26407819 | Sensitivity of neuroblastoma to the novel kinase inhibitor cabozantinib is mediated by ERK inhibition. | 2015 Nov |
2 |